Triclabendazole, HRP-conjugated

Triclabendazole, the active ingredient, is a benzimidazole. It binds to tubulin impairing intracellular transport mechanisms and interferes with protein synthesis. Triclabendazole is specifically active against Fasciola, Fascioloides and Paragonimus. The unique efficacy of FASINEX against the early immature and immature Fasciola stages makes this product particularly useful for the treatment of outbreaks of acute and subacute fasciolosis and for the strategic control of Fasciola infections. In addition, the efficacy against the 3 stages accelerates recovery of health and thus productivity. FASINEX is indicated for the treatment and control of acute, subacute and chronic fasciolosis due to early immature, immature and adult stages of Fasciola hepatica and Fasciola gigantica in cattle, sheep and goats. Anthelmintics or anti-helminthics are a class of drugs that are effective against a range of intestinal parasitic worms (helminths). The benzimidazole class of drugs were introduced in 1961 and interfere with the parasite's ATP pathway on a cellular level. They bind to a specific building block called b-tubulin and prevent its incorporation into certain cellular structures called microtubules, which are essential for energy metabolism. https://www.creative-diagnostics.com/Triclabendazole-HRP-conjugated-105776-219.htm